Primary Care Clinics in Coldwater, MS Accepting Medicare
3 Primary Care Clinics found. Showing 1 - 3
 Pravincha P. Patel, M.d. Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 423 Central Ave, Coldwater, MS 38618 Phone: 662-622-7011 |
Pravinchandra P. Patel, Md P.c. Family Medicine Medicare: Medicare Enrolled Practice Location: 423 Central Ave, Coldwater, MS 38618 Phone: 662-622-7011 Fax: 662-622-0257 |
M. J. Edwards Center Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 643 W Service Dr, Coldwater, MS 38618 Phone: 662-624-4292 Fax: 662-624-4354 |
News Archive
Mylan Pharmaceuticals receives FDA final approval for Anastrozole Tablets ANDA
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Anastrozole Tablets, 1 mg, the generic version of AstraZeneca's Arimidex® Tablets, a treatment for early breast cancer.
U.S. Food and Drug Administration launches new Center for Tobacco Products
The U.S. Food and Drug Administration today launched its new Center for Tobacco Products in an historic effort to curb the hundreds of thousands of deaths caused by those products each year.
Researchers identify new strategy to selectively sensitize cancer cells to radiation therapy
Many types of cancer become drug resistant, making them difficult to treat. Researchers with University of California San Diego School of Medicine and Moores Cancer Center have identified a strategy to selectively sensitize certain cancer cells to radiation therapy that may improve tumor control and reduce treatment-related side effects.
Compugen announces validation of IDD discovery platform for identification of cell penetrating peptides
Compugen Ltd. announced today the development and validation of its Intracellular Drug Delivery (IDD) discovery platform for identification of cell penetrating peptides. Compugen also announced that as part of the validation process for the new platform, more than twenty novel peptides, predicted and selected in silico, demonstrated the predicted cell penetrating properties in initial experimental validation studies.
› Verified 3 days ago